MeuGuru
Monju: Lose Weight on GLP-1
Snapshot
Publisher DNA
What defines MeuGuru?
AI intelligence is not yet available for MeuGuru. The portfolio data below is up to date.
Portfolio
What does MeuGuru ship?
Apps
3 apps analysed
Analysis in progress
Analysis in progress
Mounjaro, Ozempic & GLP-1: track your dose, weight, protein & progress
Integrated symptom logging facilitates clinical reporting
- AI-powered photo logging reduces daily tracking friction
Distributed across 18 markets, strongest in Europe.
Based on 2 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .
Americas (4)
- United States2 / 2
- Brazil1 / 2
- Canada1 / 2
- Mexico1 / 2
Europe (7)
- France1 / 2
- Germany1 / 2
- Italy1 / 2
- Portugal1 / 2
- Spain1 / 2
›+2 more europe markets
- Turkey1 / 2
- United Kingdom1 / 2
Asia-Pacific (7)
- Australia1 / 2
- India1 / 2
- Indonesia1 / 2
- Japan1 / 2
- Singapore1 / 2
›+2 more asia-pacific markets
- South Korea1 / 2
- Vietnam1 / 2
Core markets (2/2 apps)
Rivals
Who does MeuGuru compete with?
The rivals identified
Nemeses(2)
Both apps target users managing GLP-1 medication, with Monju focusing on nutritional outcomes and PepTracker focusing on the technical precision of peptide and medication dosing.
Both applications target the same user base of GLP-1 medication users by providing medication tracking and nutritional guidance tailored to specific side effects and protein needs.
Contenders(18)
Both apps target GLP-1 users with photo-based calorie tracking and medication logging, competing for the same weight-loss management audience.
Both apps target users managing GLP-1 medication protocols, with Monju focusing on weight loss outcomes and Dose focusing on complex compound management and inventory tracking.
Both apps target GLP-1 medication users for weight management, with Monju focusing on self-tracking tools and Body FX emphasizing physician-led consultations.
Both apps target GLP-1 patients with medication adherence and nutritional logging features, creating direct competition for users seeking clinical data organization.
Both apps target the same GLP-1 user base by providing medication injection logging and symptom tracking for weight loss journeys.
Both apps target the same GLP-1 user base with overlapping core functionality: medication dose logging, AI-powered photo calorie counting, and weight trend monitoring.
Both apps target individuals on GLP-1 medication, focusing on medication adherence and clinical reporting. Dosely competes by offering specific inventory management and injection site tracking that Monju currently lacks.
Both apps target users on GLP-1 medications like semaglutide and tirzepatide by providing dose logging and medication level visualization.
Both apps target the same GLP-1 medication user base by offering medication injection tracking, weight monitoring, and nutritional logging.
Both apps target GLP-1 users with overlapping features like dose tracking and nutritional logging, competing for the same clinical documentation and weight-loss management user base.
known for
GLP 1 Tracker: My GLP1 Journey
Both apps target GLP-1 patients with AI-assisted nutrition logging and medication dose tracking, creating direct competition for the same clinical-tracking user segment.
Both apps target users focused on protein intake for weight management, with overlapping photo-based food logging features.
Both apps target the same GLP-1 medication user base with overlapping medication, symptom, and health metric tracking features.
Both apps target the same GLP-1 medication user base by providing dose reminders, side-effect logging, and weight progress tracking for users on treatments like Mounjaro and Wegovy.
Both apps target the same GLP-1 medication user base, competing directly on medication adherence and symptom tracking features.
OneGLP targets the same GLP-1 medication user base by offering overlapping medication, symptom, and nutritional tracking features.
Both apps target GLP-1 patients requiring medication and weight tracking, creating direct competition for users seeking clinical adherence tools.
Dose Up: GLP-1 Weight Tracker competes by offering identical medication dose tracking and AI-powered nutrition logging features for the same GLP-1 patient audience.
Same space(26)
Mingo targets the same GLP-1 user base by providing a Journey Card feature that serves as evidence of progress, similar to Monju's reporting tools.
Simple uses AI and gamification to reduce logging friction, competing for users who prefer a less clinical experience.
Weight Loss Tracker - BMI offers a privacy-focused, minimalist alternative for users who prioritize data security over the clinical tracking features found in Monju.
Jabby serves the same GLP-1 patient demographic by offering a private, iCloud-synced logbook that avoids the account-based friction of other trackers.
DietApp.com bridges the gap between GLP-1 tracking and grocery logistics, offering a unique utility that Monju currently lacks.
GLPTracker serves as a digital logbook for patients to manage medication schedules and health metrics.
DreamMe uses gamification to target the same GLP-1 audience, providing a companion-based retention hook that differentiates it from Monju's clinical utility.
Formula focuses on specific diet plans like carnivore and keto, targeting users seeking structured nutritional guidance.
Foodvisor serves the same nutrition-tracking audience as Monju but focuses on general-purpose AI food recognition rather than clinical GLP-1 adherence.
Free GLP 1 Tracker Dr.GLP1 provides a comprehensive alternative to Monju by including specific tools for injection site rotation and muscle protection.
Glapp targets the same GLP-1 user base with a community-driven approach, emphasizing peer data comparison over the clinical focus of Monju.
Revio targets the same GLP-1 patient segment but differentiates through Apple Watch integration, creating a persistent engagement loop on the user's wrist.
DailyP competes with the protein logging feature by focusing exclusively on protein intake.
SmartDiet provides a simplified, non-clinical alternative for users who find specialized GLP-1 trackers like Monju too complex for daily weight monitoring.
MeAgain targets the same medication-adherence segment but uses a mascot-based widget to drive daily retention, contrasting with Monju's AI-focused approach.
Noom competes for the same weight-loss audience by layering behavioral psychology over clinical GLP-1 support, offering a broader curriculum than Monju.
GLP 1 Tracker: Shot Pal serves the same GLP-1 and diabetes management audience as Monju, focusing on medication scheduling and progress visualization.
Shotsy serves the same high-intent GLP-1 audience by focusing on clinical-grade medication level visualization rather than just basic meal logging.
GLP-1 Weight Loss Tracker: Pep competes directly with Monju by centralizing medication adherence and AI-driven nutrition logging for the same patient demographic.
Stackr targets the broader peptide and GLP-1 user base, offering more granular supply management than Monju's clinical-focused tracking.
GLP-1 Tracker serves the same medication-adherence audience but differentiates through biometric security, which Monju does not explicitly feature.
GLP Diet focuses on the nutritional aspect of the GLP-1 journey, offering a structured coaching approach that complements Monju's tracking utility.
Zepbound & Mounjaro Tracker provides a direct feature-set overlap with Monju by combining medication history with nutritional logging and progress photos.
Dose AI combines medication logging with nutrition and symptom tracking for GLP-1 patients.
Glowise targets the same GLP-1 user base by combining nutrition tracking with symptom monitoring, though it lacks the depth of Monju's clinical reporting.
Pep AI provides a specialized tracking tool for GLP-1 and peptide research, focusing on inventory and calculations.